Abstract
Hepatoprotectors are one of the important categories of drugs prescribed to patients with acute and severe conditions accompanied by impairment of the liver function. In view of the importance of this problem, at the end of 2017 the Government of the Russian Federation approved a new list of vital and essential medicinal products for human use for 2018, which included the original drug developed by the Russian researchers - the infusion hepatoprotector Remaxol®.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have